These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6212678)

  • 1. Suppressor cell activity in progressive systemic sclerosis.
    Krawitt EL; Holdstock G; Bland JH; Chastenay BF; Albertini RJ
    J Rheumatol; 1982; 9(2):263-7. PubMed ID: 6212678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.
    Alarcón-Segovia D; Palacios R; Ibáñez de Kasep G
    J Clin Lab Immunol; 1981 May; 5(3):143-8. PubMed ID: 6453999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function.
    Krakauer RS; Sundeen J; Sauder DN; Scherbel A
    Arch Dermatol; 1981 Feb; 117(2):80-2. PubMed ID: 6451199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.
    Segond P; Salliere D; Galanaud P; Desmottes RM; Massias P; Fiessinger JN
    Clin Exp Immunol; 1982 Jan; 47(1):147-54. PubMed ID: 6212171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
    Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
    J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific suppressor cell activity in patients with scleroderma.
    Keystone EC; Gladman DD; Baron M; Cane D; Poplonski L
    J Rheumatol; 1981; 8(5):747-51. PubMed ID: 6171643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
    Smith MD; Hardy G; Williams JD; Coles GA
    Clin Nephrol; 1983 Sep; 20(3):130-5. PubMed ID: 6226465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.
    Soppi E; Lehtonen A; Toivanen A
    Clin Exp Immunol; 1982 Nov; 50(2):275-82. PubMed ID: 6217932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies.
    Keystone EC; Lau C; Gladman DD; Wilkinson S; Lee P; Shore A
    Clin Exp Immunol; 1982 May; 48(2):443-8. PubMed ID: 6213329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
    Oger JJ; Antel JP; Kuo HH; Arnason BG
    Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor leukocytes in anergic patients with solid tumors.
    Bankhurst AD; Kauffman GR; Goodwin JS; Saiki JH; Saiers JH; Williams RC
    J Clin Lab Immunol; 1980 May; 3(3):159-63. PubMed ID: 6448298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.
    de Galocsy C; Jenkins PJ; Mieli-Vergani G; Eddleston AL; Williams R
    Clin Exp Immunol; 1981 Mar; 43(3):486-90. PubMed ID: 6456855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of polymorphonuclear leukocyte (PMNL) factors on T suppressor cell function in in vitro studies in healthy persons and some autoimmune disorders.
    Czernicki J; Tchórzewski H; Lewicki R; Orzel H
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):355-60. PubMed ID: 6457583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R; Kuriki J; Kakumu S
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).
    Tomino S; Fujiwara H; Kagimoto T; Mitsuya H; Nishimura H; Kishimoto S
    Clin Exp Immunol; 1982 Jun; 48(3):625-32. PubMed ID: 6214341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of suppressor T cell function in patients with rheumatoid arthritis: defects in production of and responsiveness to concanavalin A-induced suppressor T cells.
    Sakane T; Takada S; Murakawa Y; Kotani H; Honda M; Ueda Y
    J Immunol; 1982 Nov; 129(5):1972-7. PubMed ID: 6214584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.